Living Cell-Based Drug Delivery Systems for Biomedical Applications
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: closed (31 October 2022) | Viewed by 9409
Special Issue Editor
Special Issue Information
Dear Colleagues,
Over the past few decades, drug delivery technologies have enabled the development of many pharmaceutical products that improve patient health by enhancing the delivery of a therapeutic to its target site, minimizing off-target accumulation and facilitating patient compliance. Living drug delivery systems, such as engineering living immune cells, stem cells, platelets, bacterial cells, etc. with various therapeutics (proteins, peptides, small molecules, cytokins, genes) or functional groups, as newly emerging paradigms for anticancer/ anti-inflammation therapy or tissue regeneration, have shown great potential in translational medicine research. In this Special Issue, we invite authors to report their recently developed living-cell-based drug delivery systems for biomedical applications. We also welcome review articles with expert opinions and perspectives in the biomedical field.
Dr. Haiqing Dong
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- drug delivery
- living delivery
- T cells
- macrophages
- NK cells
- neutrophils
- immune cells
- stem cells
- red blood cells
- bacterial cells
- microbes
- anticancer therapy
- immunotherapy
- anti-inflammation
- tissue regeneration
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.